
Am J Psychiatry 155:603-609, May 1998
© 1998 American Psychiatric Association
Comparison of Aerobic Exercise, Clomipramine, and Placebo in the Treatment of Panic Disorder
Andreas Broocks, M.D.,
Borwin Bandelow, M.D.,
Gunda Pekrun, M.A.,
Annette George, M.D.,
Tim Meyer, M.D.,
Uwe Bartmann, M.A.,
Ursula Hillmer-Vogel, M.D., and
Eckart Rüther, M.D.
OBJECTIVE: The purpose of this study was to compare the therapeutic effect of exercise for patients with panic disorder to a drug treatment of proven efficacy and to placebo. METHOD: Forty-six outpatients suffering from moderate to severe panic disorder with or without agoraphobia (DSM-III-R criteria) were randomly assigned to a 10-week treatment protocol of regular aerobic exercise (running), clomipramine (112.5 mg/day), or placebo pills. RESULTS: The dropout rate was 31% for the exercise group, 27% for the placebo group, and 0% for the clomipramine group. In comparison with placebo, both exercise and clomipramine led to a significant decrease in symptoms according to all main efficacy measures (analysis of variance, last-observation-carried-forward method and completer analysis). A direct comparison of exercise and clomipramine revealed that the drug treatment improved anxiety symptoms significantly earlier and more effectively. Depressive symptoms were also significantly improved by exercise and clomipramine treatment. CONCLUSIONS: These results suggest that regular aerobic exercise alone, in comparison with placebo, is associated with significant clinical improvement in patients suffering from panic disorder, but that it is less effective than treatment with clomipramine.
This article has been cited by other articles:

|
 |

|
 |
 
E. W. Martinsen and J. S. Raglin
Themed Review: Anxiety/Depression: Lifestyle Medicine Approaches
American Journal of Lifestyle Medicine,
May 1, 2007;
1(3):
159 - 166.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Strohle, C. Feller, M. Onken, F. Godemann, A. Heinz, and F. Dimeo
The Acute Antipanic Activity of Aerobic Exercise
Am J Psychiatry,
December 1, 2005;
162(12):
2376 - 2378.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al.
Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology
J Psychopharmacol,
November 1, 2005;
19(6):
567 - 596.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
I. MARKS
Treatment of Panic Disorder
Am J Psychiatry,
July 1, 1999;
156(7):
1129 - 1129.
[Full Text]
|
 |
|
Get information about faster international access.
a>
Privacy Policy
Copyright © 1998
American Psychiatric Association.
All rights reserved.
Home
| Search
| Current Issue
| Past Issues
| Subscribe
| All APPI Journals
| Help
| Contact Us
|